Found 16 matching trials
Evaluate the Efficacy, Immunogenicity and Safety of 9-valent HPV Recombinant Vaccine in Chinese Healthy Females PHASE3 This study is designed to evaluate the vaccine efficacy, immunogenicity and...
Show More Location
Liuzhou center for disease control and prevention
Learn More & Join Trial
Efficacy, Immunogenicity and Safety of V503 in Chinese Women Aged 20-45 Years (V503-023) PHASE3 This study will evaluate the efficacy, immunogenicity and safety of 9-valen...
Show More Status
Active Not Recruiting
Location
Lingchuan Center for Disease Control and Prevention ( Site 0002)
Learn More & Join Trial
Evaluate the Immunogenicity and Safety of 9-valent HPV Recombinant Vaccine in Chinese Healthy Females PHASE3 The study will evaluate the immunogenicity and safety of 9-valent HPV recom...
Show More Location
Guangxi Zhuang Autonomous Region Center for Disease Control and Prevention
Learn More & Join Trial
HPV Vaccination in HIV Infected and HIV Uninfected Adolescents in Eswatini PHASE4 This is a multi-site, open-label non-inferiority study of the 9vHPV vaccine...
Show More Learn More & Join Trial
Nonavalent HPV Vaccine in the Treatment of Difficult-to-treat Palmo-plantar Warts PHASE3 Cutaneous viral warts are very common and are caused by the human papilloma...
Show More Learn More & Join Trial
Phase III Study Comparing the Immunogenicity of 9-valent HPV Recombinant Vaccine and Gardasil-9 PHASE3 This study will evaluate the immunogenicity and safety of Zerun 9-valent HP...
Show More Location
GuangXi Center for Diseases Control and Prevention
Learn More & Join Trial
A Phase II Study of SCT1000 in Healthy Women Aged 18 to 45 Years PHASE2 A phase II random, double blind, positive and placebo control trail was con...
Show More Location
Guanyun Country CDC
Learn More & Join Trial
Vaccination Against Human Papillomavirus (HPV) After Allogeneic Stem Cell Transplantation PHASE2 Patients who undergo allogeneic stem cell transplantation lose previously a...
Show More Location
Skåne's University Hospital
Learn More & Join Trial
Immunogenicity of the 9vHPV Vaccination 2-dose Regimen Among Children 4 to 8 Years Old EARLY_PHASE1 This study is an open-label nonrandomized exploratory proof of concept and ...
Show More Status
Active Not Recruiting
Location
Boston Medical Center
Learn More & Join Trial
Safety and Immunogenicity of 9-valent Human Papillomavirus (9vHPV) Vaccine Coadministered With Messenger Ribonucleic Acid (mRNA)-1273 Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) (COVID-19) Vaccine (V503-076) PHASE3 The purpose of this study to evaluate the safety and immunogenicity of a 2-...
Show More Location
Cognitive Clinical Trials, LLC ( Site 0054)
Learn More & Join Trial